Inhibitors of ADAMTS13: a potential factor in the cause of thrombotic microangiopathy in a renal allograft recipient-Reference-Cited by-同舟云学术

Inhibitors of ADAMTS13: a potential factor in the cause of thrombotic microangiopathy in a renal allograft recipient

Published:2002-10 Issue:8 Volume:74 Page:1077-1080
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Pham Phuong-Thu T.,Danovitch Gabriel M.,Wilkinson Alan H.,Gritsch H. Albin,Pham Phuong-Chi T.,Eric Tong M.,Kendrick Elizabeth,Charles Lassman R.,Tsai Han-Mou

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference25 articles.

1. Cyclosporine-associated thrombotic microangiopathy in renal allografts

2. von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

3. Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura

4. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Incidence and Graft Survival Rate in Kidney Transplant Recipients With De Novo Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis;Transplant International;2024-01-23

2. A case of “smoldering” immune‐mediated thrombotic thrombocytopenic purpura manifesting as recurrent cardioembolic stroke;Clinical Case Reports;2021-10

3. Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity;Frontiers in Medicine;2021-04-08

4. Cytopenias in Transplant Patients;Principles and Practice of Transplant Infectious Diseases;2019

5. Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease;World Journal of Transplantation;2018-09-10